Smart Immune

Smart Immune

Recherche en biotechnologie

Paris, Île-de-France 5 514 abonnés

Pioneering thymus-empowered T-cell platform to fight cancer and infection

À propos

Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments like off-the-shelf CAR T. The Company is headquartered in Paris, France, at Paris Biotech Santé.

Site web
http://www.smart-immune.com
Secteur
Recherche en biotechnologie
Taille de l’entreprise
11-50 employés
Siège social
Paris, Île-de-France
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2017
Domaines
Biotechnology, Cell therapy, CAR T, Immuno-oncology, NK cells, T cells, Immune reconstitution, T cell progenitors, Lymphoid progenitors, Naive cells, HSC differentiation et Thymic selection

Lieux

  • Principal

    Paris Biotech santé - Pole innovation 29, Rue du Faubourg Saint-Jacques

    75014 Paris, Île-de-France, FR

    Obtenir l’itinéraire

Employés chez Smart Immune

Nouvelles

Pages similaires

Parcourir les offres d’emploi

Financement

Smart Immune 5 rounds en tout

Dernier round

Subside

5 000 000,00 $US

Voir plus d’informations sur Crunchbase